Table 1 presents the baseline characteristics of participants from the five survey waves. Participants were surveyed in 2011 (1,754 participants), 2013 (1,454 participants), 2015 (1,848 participants), 2018 (5,239 participants), and 2020 (5,260 participants), with a total of 15,555 person-times participating in the study. Overall, the average age was 63.02 ± 9.84 years, and the gender distribution was relatively balanced, with 51.92% being female and 48.08% being male. Most participants were married (83.09%), and more than 60% (64.56%) resided in rural areas, with only 35.44% living in urban areas. The majority of participants were still not retired (86.55%). Regarding lifestyle, 58.44% of participants were non-smokers, while 41.56% were smokers; 66.26% did not drink alcohol, while 33.74% reported drinking habits. In terms of physical activity, the participants' total metabolic equivalent (Total MET) gradually decreased from 7,722.48 ± 7,338.38 in 2011 to 6,432.14 ± 6,038.67 in 2020, with an average of 6,899.65 ± 6,574.28 over the study period. The participation rate in vigorous activity was 37.96%, moderate-intensity activity was 55.98%, and 81.95% of participants engaged in light activity. 62.04% did not engage in vigorous activities, while 37.96% participated in such activities; 44.02% did not perform moderate-intensity activities, while 55.98% engaged in them; and 81.95% of participants were involved in light activities. In terms of health, the prevalence of heart disease was 16.98%, stroke was 5.34%, and hypertension was 35.74%, while the rate of dyslipidemia was 18.05%. Additionally, asthma (6.07%), lung disease (16.68%), diabetes (10.77%), arthritis (46.78%), gastric diseases (33.65%), kidney disease (11.24%), and liver disease (6.8%) showed varying levels of prevalence across the different survey waves. Overall, participants' health status, lifestyle, and physical activity patterns exhibited certain trends over the five surveys, reflecting associations between these variables and various chronic diseases.
Table 1
Baseline characteristics of participants.
Variable | wave 1 (2011) | wave 2 (2013) | wave 3(2015) | wave 4 (2018) | wave 5 (2020) | Total | P |
Observations, n | | | | | | < 0.01 |
| 1754 | 1454 | 1848 | 5239 | 5260 | 15555 | |
Age, mean ± SD | | | | | | < 0.01 |
| 59.73 ± 9.77 | 60.34 ± 9.65 | 61.74 ± 9.42 | 63.44 ± 9.89 | 64.89 ± 9.51 | 63.02 ± 9.84 | |
Total MET, mean ± SD | | | | | | < 0.01 |
| 7722.48 ± 7338.38 | 7245.31 ± 7116.07 | 7564.78 ± 6867.05 | 6761.69 ± 6508.19 | 6432.14 ± 6038.67 | 6899.65 ± 6574.28 | |
Gender, n (%) | | | | | | 0.25 |
Female | 936 (53.36) | 786 (54.06) | 951 (51.46) | 2696 (51.25) | 2707 (51.67) | 8076 (51.92) | |
Male | 818 (46.64) | 668 (45.94) | 897 (48.54) | 2564 (48.75) | 2532 (48.33) | 7479 (48.08) | |
Marital Status, n (%) | | | | | | < 0.01 |
Non-married | 252 (14.37) | 213 (14.65) | 262 (14.18) | 921 (17.51) | 983 (18.76) | 2631 (16.91) | |
Married | 1502 (85.63) | 1241 (85.35) | 1586 (85.82) | 4339 (82.49) | 4256 (81.24) | 12924 (83.09) | |
Residence, n (%) | | | | | | 0.04 |
No | 580 (33.07) | 537 (36.93) | 623 (33.71) | 1911 (36.33) | 1861 (35.52) | 5512 (35.44) | |
Yes | 1174 (66.93) | 917 (63.07) | 1225 (66.29) | 3349 (63.67) | 3378 (64.48) | 10043 (64.56) | |
Retire, n (%) | | | | | | < 0.01 |
No | 1561 (89) | 1261 (86.73) | 1630 (88.2) | 4569 (86.86) | 4442 (84.79) | 13463 (86.55) | |
Yes | 193 (11) | 193 (13.27) | 218 (11.8) | 691 (13.14) | 797 (15.21) | 2092 (13.45) | |
Smoke, n (%) | | | | | | < 0.01 |
No | 1109 (63.23) | 887 (61) | 1050 (56.82) | 3025 (57.51) | 3020 (57.64) | 9091 (58.44) | |
Yes | 645 (36.77) | 567 (39) | 798 (43.18) | 2235 (42.49) | 2219 (42.36) | 6464 (41.56) | |
Drinkl, n (%) | | | | | | < 0.01 |
No | 1190 (67.84) | 977 (67.19) | 1215 (65.75) | 3553 (67.55) | 3371 (64.34) | 10306 (66.26) | |
Yes | 564 (32.16) | 477 (32.81) | 633 (34.25) | 1707 (32.45) | 1868 (35.66) | 5249 (33.74) | |
physical activity, n (%) | | | | | | |
Vigorous-intensity | | | | | | < 0.01 |
No | 1099 (62.66) | 904 (62.17) | 1115 (60.34) | 3420 (65.02) | 3112 (59.4) | 9650 (62.04) | |
Yes | 655 (37.34) | 550 (37.83) | 733 (39.66) | 1840 (34.98) | 2127 (40.6) | 5905 (37.96) | |
Moderate activity | | | | | | < 0.01 |
No | 738 (42.08) | 605 (41.61) | 739 (39.99) | 2594 (49.32) | 2171 (41.44) | 6847 (44.02) | |
Yes | 1016 (57.92) | 849 (58.39) | 1109 (60.01) | 2666 (50.68) | 3068 (58.56) | 8708 (55.98) | |
Light-intensity | | | | | | < 0.01 |
No | 319 (18.19) | 217 (14.92) | 300 (16.23) | 873 (16.6) | 1098 (20.96) | 2807 (18.05) | |
Yes | 1435 (81.81) | 1237 (85.08) | 1548 (83.77) | 4387 (83.4) | 4141 (79.04) | 12748 (81.95) | |
Disease, n (%) | | | | | | |
hearte | | | | | | < 0.01 |
No | 1573 (89.68) | 1295 (89.06) | 1546 (83.66) | 4292 (81.6) | 4208 (80.32) | 12914 (83.02) | |
Yes | 181 (10.32) | 159 (10.94) | 302 (16.34) | 968 (18.4) | 1031 (19.68) | 2641 (16.98) | |
stroke | | | | | | < 0.01 |
No | 1709 (97.43) | 1423 (97.87) | 1802 (97.51) | 4911 (93.37) | 4880 (93.15) | 14725 (94.66) | |
Yes | 45 (2.57) | 31 (2.13) | 46 (2.49) | 349 (6.63) | 359 (6.85) | 830 (5.34) | |
hibpe | | | | | | | < 0.01 |
No | 1317 (75.09) | 1076 (74) | 1255 (67.91) | 3199 (60.82) | 3148 (60.09) | 9995 (64.26) | |
Yes | 437 (24.91) | 378 (26) | 593 (32.09) | 2061 (39.18) | 2091 (39.91) | 5560 (35.74) | |
dyslipe | | | | | | < 0.01 |
No | 1620 (92.36) | 1297 (89.2) | 1554 (84.09) | 4264 (81.06) | 4013 (76.6) | 12748 (81.95) | |
Yes | 134 (7.64) | 157 (10.8) | 294 (15.91) | 996 (18.94) | 1226 (23.4) | 2807 (18.05) | |
asthmae | | | | | | < 0.01 |
No | 1676 (95.55) | 1390 (95.6) | 1749 (94.64) | 4906 (93.27) | 4890 (93.34) | 14611 (93.93) | |
Yes | 78 (4.45) | 64 (4.4) | 99 (5.36) | 354 (6.73) | 349 (6.66) | 944 (6.07) | |
lunge | | | | | | < 0.01 |
No | 1540 (87.8) | 1269 (87.28) | 1553 (84.04) | 4250 (80.8) | 4348 (82.99) | 12960 (83.32) | |
Yes | 214 (12.2) | 185 (12.72) | 295 (15.96) | 1010 (19.2) | 891 (17.01) | 2595 (16.68) | |
diabe | | | | | | < 0.01 |
No | 1677 (95.61) | 1367 (94.02) | 1681 (90.96) | 4629 (88) | 4526 (86.39) | 13880 (89.23) | |
Yes | 77 (4.39) | 87 (5.98) | 167 (9.04) | 631 (12) | 713 (13.61) | 1675 (10.77) | |
arthre | | | | | | < 0.01 |
No | 1022 (58.27) | 837 (57.57) | 869 (47.02) | 2741 (52.11) | 2809 (53.62) | 8278 (53.22) | |
Yes | 732 (41.73) | 617 (42.43) | 979 (52.98) | 2519 (47.89) | 2430 (46.38) | 7277 (46.78) | |
digeste | | | | | | < 0.01 |
No | 1291 (73.6) | 1024 (70.43) | 1175 (63.58) | 3436 (65.32) | 3395 (64.8) | 10321 (66.35) | |
Yes | 463 (26.4) | 430 (29.57) | 673 (36.42) | 1824 (34.68) | 1844 (35.2) | 5234 (33.65) | |
kidneye | | | | | | < 0.01 |
No | 1632 (93.04) | 1341 (92.23) | 1637 (88.58) | 4612 (87.68) | 4585 (87.52) | 13807 (88.76) | |
Yes | 122 (6.96) | 113 (7.77) | 211 (11.42) | 648 (12.32) | 654 (12.48) | 1748 (11.24) | |
livere | | | | | | < 0.01 |
No | 1688 (96.24) | 1388 (95.46) | 1738 (94.05) | 4849 (92.19) | 4834 (92.27) | 14497 (93.2) | |
Yes | 66 (3.76) | 66 (4.54) | 110 (5.95) | 411 (7.81) | 405 (7.73) | 1058 (6.8) | |
Figure 1 and Table S1 presents the associations between different physical activity levels, categorized by metabolic equivalents, and various chronic diseases. In the analysis of Model 3, compared to low physical activity levels, moderate and high physical activity significantly reduced the risk of multiple chronic diseases. Specifically, moderate physical activity significantly reduced the risk of heart disease, stroke, and asthma, with ORs of 0.84 (95% CI: 0.74, 0.97, P = 0.02), 0.67 (95% CI: 0.55, 0.82, P < 0.01), and 0.75 (95% CI: 0.60, 0.93, P = 0.02), respectively. However, moderate physical activity was associated with an increased risk of dyslipidemia and diabetes, with ORs of 1.51 (95% CI: 1.31, 1.74, P < 0.01) and 1.22 (95% CI: 1.03, 1.44, P = 0.02). With high levels of physical activity, the risks of heart disease, stroke, asthma, and hypertension further decreased, with ORs of 0.66 (95% CI: 0.58, 0.75, P < 0.01), 0.50 (95% CI: 0.41, 0.60, P < 0.01), 0.61 (95% CI: 0.51, 0.75, P < 0.01), and 0.79 (95% CI: 0.71, 0.87, P < 0.01), respectively. However, high levels of physical activity were associated with an increased risk of arthritis and kidney disease, with ORs of 1.18 (95% CI: 1.07, 1.30, P < 0.01) and 1.32 (95% CI: 1.13, 1.55, P < 0.01). Overall, moderate and high levels of physical activity significantly reduced the risks of cardiovascular and respiratory diseases, although increased physical activity levels were also associated with higher risks of metabolic and joint-related diseases in some cases.
Figure 2 and Table S2 shows the associations between moderate and high physical activity levels and multimorbidity, with participants having one disease serving as the baseline group. At moderate levels of physical activity, the risks of having two, three, four, and five or more diseases did not significantly differ from the baseline group, with ORs of 1.04 (95% CI: 0.88, 1.22, P = 0.70), 0.97 (95% CI: 0.81, 1.15, P = 0.66), 1.03 (95% CI: 0.84, 1.25, P = 0.84), and 0.85 (95% CI: 0.70, 1.02, P = 0.06), respectively. However, with high levels of physical activity, the risks of having three or more diseases significantly decreased. Specifically, the risks for having three, four, and five or more diseases were 0.82 (95% CI: 0.70, 0.95, P < 0.01), 0.79 (95% CI: 0.66, 0.94, P < 0.01), and 0.55 (95% CI: 0.47, 0.65, P < 0.01), respectively. In summary, high levels of physical activity significantly reduced the risk of multimorbidity, particularly for three or more diseases, while the impact of moderate activity in this area was relatively small.
Figure 3 and Fig. 4 illustrate potential nonlinear dose-response relationships between total physical activity (Total MET) and various chronic diseases. Overall, cardiovascular diseases, including heart disease (hearte), stroke (stroke), and hypertension (hibpe), showed significant decreases with increasing physical activity levels, exhibiting similar nonlinear associations (P overall < 0.01, P nonlinear < 0.01). The increase in Total MET significantly reduced the risk of these diseases, especially at lower activity levels (< 10,000 MET-h), after which the reduction plateaued. For respiratory diseases, asthma (asthmae) and lung disease (lunge) displayed different trends. The increase in Total MET was significantly negatively correlated with asthma risk (P overall < 0.01, P nonlinear = 0.02), indicating that physical activity helps reduce asthma risk. However, for lung disease, the curve did not show a clear dose-response relationship (P overall = 0.23, P nonlinear = 0.62), suggesting a weaker impact of physical activity on lung disease risk. Metabolic diseases, such as dyslipidemia (dyslipe) and diabetes (diabe), also showed different patterns. The relationship between Total MET and dyslipidemia remained relatively stable, with no significant nonlinear effect (P nonlinear = 0.97). In contrast, the risk of diabetes decreased with increased activity levels, showing a significant association (P overall < 0.01, P nonlinear = 0.74), indicating the protective role of physical activity against diabetes. Moreover, the risks of arthritis (arthre) and kidney disease (kidney) increased with high levels of physical activity (arthritis: P overall = 0.09, P nonlinear = 0.34; kidney disease: P overall = 0.19, P nonlinear = 0.26). In summary, there is a significant dose-response relationship between total physical activity and various chronic diseases, particularly for cardiovascular and respiratory diseases, where increased physical activity levels significantly reduced disease risk. However, for some diseases, such as arthritis and kidney disease, higher activity levels were associated with an increased risk.
Table S3-8 present the results of stratified analyses of moderate and high physical activity levels and their associations with various chronic diseases, stratified by gender, age, marital status, place of residence, retiremalet status, smoking, and drinking habits. In these stratified analyses, moderate and high physical activity levels were significantly associated with the risk of various chronic diseases, with the association varying by gender, age, marital status, residence, retiremalet status, smoking, and drinking habits. Overall, the risks of heart disease and stroke were significantly reduced across different strata. For both male and female, high physical activity significantly reduced the risks of heart disease (male, OR = 0.54, 95% CI: 0.45, 0.64; female, OR = 0.64, 95% CI: 0.55, 0.75) and stroke (male, OR = 0.46, 95% CI: 0.36, 0.60; female, OR = 0.40, 95% CI: 0.31, 0.51). Stratified by age, the protective effects of high physical activity on heart disease (OR = 0.53, 95% CI: 0.44, 0.63) and stroke (OR = 0.38, 95% CI: 0.28, 0.51) were particularly pronounced in those under 65 years old. In those aged ≥ 65 years, while the effects were weaker, they still significantly reduced the risks of heart disease (OR = 0.57, 95% CI: 0.49, 0.66) and stroke (OR = 0.41, 95% CI: 0.33, 0.51).
Table 2 and Table S9 present the stratified analysis results of the relationship between moderate and high levels of physical activity and multimorbidity (two, three, four, and five or more diseases) according to gender, age, marital status, residence, retirement status, smoking, and drinking habits. At moderate activity levels, gender, age, marital status, and residence did not show significant differences, but retirement status had a significant effect in the strata with three or more diseases, with the non-retired group having a lower OR (OR = 0.44, 95% CI: 0.28, 0.69, p < 0.01). At high activity levels, the effect of retirement status was even more pronounced, with non-retired individuals having a significantly lower OR than retired ones. Meanwhile, differences in smoking and drinking habits were not significant. For those with high activity levels, the risk of multimorbidity was significantly reduced among unmarried individuals, those under 65 years of age, rural residents, and non-retired individuals, especially in the strata with five or more diseases. For example, the OR for those under 65 was 0.44 (95% CI: 0.35, 0.55, p < 0.01). These results suggest that the relationship between physical activity levels and multimorbidity varies across different demographic characteristics, particularly in the stratified analysis of retirement status and age.
Table 2
Stratified analysis of the effect of high physical activity on multimorbidity (two, three, four, or five or more diseases), categorized by gender, age, marital status, place of residence, retirement status, smoking, and drinking habits.
Character | Multimorbidity Category (OR [95% CI], p-value) | |
Two Diseases | P_int | Three Diseases | P_int | Four Diseases | P_int | Five or More Diseases | P_int |
Gender | | 0.83 | | 0.37 | | 0.13 | | 0.28 |
Female | 0.93 (0.76, 1.15), 0.52 | | 0.88 (0.70, 1.10), 0.26 | | 0.63 (0.49, 0.83), < 0.01 | | 0.49 (0.38, 0.62), < 0.01 | |
Male | 0.94 (0.78, 1.14), 0.54 | | 0.78 (0.63, 0.95), 0.02 | | 0.92 (0.73, 1.18), 0.52 | | 0.6 (0.48, 0.75), < 0.01 | |
Age | | 0.26 | | 0.28 | | 0.05 | | 0.90 |
< 65 | 0.77 (0.63, 0.95), 0.01 | | 0.65 (0.52, 0.80), < 0.01 | | 0.67 (0.53, 0.86), < 0.01 | | 0.44 (0.35, 0.55), < 0.01 | |
≥ 65 | 1.02 (0.83, 1.24), 0.85 | | 0.89 (0.71, 1.12), 0.33 | | 0.78 (0.59, 1.03), 0.08 | | 0.55 (0.42, 0.71), < 0.01 | |
Marital Status | 0.34 | | 0.81 | | 0.30 | | 0.67 |
Non-married | 0.97 (0.83, 1.15), 0.76 | | 0.80 (0.68, 0.96), 0.01 | | 0.76 (0.62, 0.94), 0.01 | | 0.56 (0.46, 0.68), < 0.01 | |
Married | 0.76 (0.56, 1.02), 0.07 | | 0.73 (0.52, 1.01), 0.06 | | 0.79 (0.55, 1.13), 0.20 | | 0.46 (0.33, 0.64), < 0.01 | |
Residence | | 0.66 | | 0.43 | | 0.69 | | 0.38 |
Urban | 0.91 (0.77, 1.09), 0.31 | | 0.83 (0.69, 0.99), 0.05 | | 0.79 (0.64, 0.98), 0.03 | | 0.58 (0.48, 0.72), < 0.01 | |
Rural | 0.99 (0.77, 1.27), 0.92 | | 0.76 (0.58, 0.99), 0.04 | | 0.76 (0.55, 1.05), 0.09 | | 0.48 (0.36, 0.64), < 0.01 | |
Retire | | 0.17 | | 0.06 | | 0.07 | | 0.09 |
No | 0.70 (0.45, 1.08), 0.11 | | 0.55 (0.35, 0.86), 0.01 | | 0.50 (0.31, 0.82), 0.01 | | 0.38 (0.24, 0.59), < 0.01 | |
Yes | 0.97 (0.84, 1.13), 0.70 | | 0.86 (0.73, 1.01), 0.06 | | 0.84 (0.69, 1.02), 0.08 | | 0.58 (0.49, 0.70), < 0.01 | |
Smoke | | 0.90 | | 0.77 | | 0.65 | | 0.41 |
No | 0.97 (0.78, 1.21), 0.80 | | 0.84 (0.66, 1.07), 0.16 | | 0.73 (0.55, 0.98), 0.03 | | 0.49 (0.38, 0.64), < 0.01 | |
Yes | 0.92 (0.76, 1.10), 0.36 | | 0.8 (0.65, 0.97), 0.03 | | 0.82 (0.65, 1.03), 0.09 | | 0.59 (0.47, 0.73), < 0.01 | |
Drink | | 0.76 | | 0.37 | | 0.72 | | 0.77 |
No | 0.93 (0.78, 1.10), 0.39 | | 0.93 (0.69, 1.25), 0.63 | | 0.84 (0.59, 1.20), 0.34 | | 0.62 (0.44, 0.88), 0.01 | |
Yes | 0.97 (0.75, 1.26), 0.83 | | 0.78 (0.65, 0.93), 0.01 | | 0.78 (0.63, 0.96), 0.02 | | 0.54 (0.45, 0.65), < 0.01 | |